Press Releases
-
eClinical Solutions Welcomes Sean Lannan as Chief
Lannan and new Board of Directors member Jason Blessing will help propel the company’s next phase of growth
May 14, 2025
-
Abzena Announces Establishment of Scientific Advisory Board to Support Innovation Strategy
-
CapeStart Helps Life Science Teams Scale Faster, Boost Productivity with New Release of MadeAi™, Award-Winning GenAI Platform
CapeStart announced a major new release of MadeAi™, its GenAI-based platform that expedites the synthesis of content and data for the life sciences. The platform and the MadeAi-LR solution for systematic literature review (SLR) help time-strapped teams to advance the pace of scientific research.
May 13, 2025
-
START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors
This major study milestone highlights START’s commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials.
May 14, 2025
-
Inizio Evoke Supercharges Creative Leadership with Dual ECD Appointments
-
ELRIG Announces Keynote Speakers for Drug Discovery 2025
• Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event • Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science” • Event supported by VisitBritain showcases UK life science sector and extends international reach
May 6, 2025
-
GenNext Technologies and Thermo Fisher Scientific Collaborate to Simplify Structural Biology for Faster Biotherapeutic Development
GenNext® Technologies, Inc. is collaborating with Thermo Fisher Scientific to provide a simplified structural biology workflow designed to improve biotherapeutic development
May 6, 2025
-
Hovione and Firstgene announce strategic collaboration to advance virus-like particle platform for liver cancer
-
Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development
Elegen expanded it's ENFINIA cell-free gene synthesis platform with the launch of an early access program for IVT Ready DNA targeted toward RNA therapeutics, cell and gene therapies, and personalized cancer vaccines. ENFINIA IVT Ready DNA offers full-length, high-complexity, high-accuracy linear DNA with a long poly(A) tail, manufactured cell-free and delivered in as few as 10 days, ready for immediate use to speed genetic medicine development.
May 6, 2025
-
GeneFab and RegCell Announce Strategic Partnership to Advance Autoimmune Cell Therapy into U.S. Clinical Trials
-
Mayo Clinic Study Uses Phenomix AI Algorithm to Predict GLP-1 Side Effects, Advancing Personalized Obesity Care and Drug Development
Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies, supporting the development of more targeted treatment decisions and advancing pharmaceutical R&D.
May 6, 2025
-
Gifthealth Appoints Chip Parkinson as Chief Executive Officer to Accelerate Growth and Innovation in Pharmacy Services
Gifthealth, a technology-driven pharmacy care company dedicated to making prescription access easier and more affordable, is pleased to announce the appointment of Chip Parkinson as its new Chief Executive Officer.
May 6, 2025
-
Emmes Groups' OptymEdge to launch the first dedicated ophthalmology clinical trial platform at ARVO 2025
-
Symbiosis Honoured with Prestigious King’s Award for Enterprise for International Trade
-
Symbiosis Completes Successful MHRA Audit of New Sterile Fill/Finish Facility, Expanding Global Manufacturing Capacity
-
Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF
-
Viz.ai Launches Viz 3D CTA™ to Deliver Enhanced Imaging and Accelerate Clinical Decision-Making
New feature provides AI-enhanced 3D imaging to improve neurovascular visualization and streamline workflows.
Apr 29, 2025
-
EpiCypher Launches Novel, Affordable DNA Methylation Sequencing Assays to Accelerate Drug Discovery
EpiCypher® has announced the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery.
Apr 24, 2025
-
Aplos Analytics Expands Cloud-Based Platform to Include Custom Outputs
Aplos NCA includes new features to support custom data processing, flexible table and figure creation, and the ability to create custom reports using user-defined templates.
Apr 24, 2025
-
Mundipharma announces availability of REZZAYO® (rezafungin) for adult patients with invasive candidiasis following Health Service Executive reimbursement agreement1